Literature DB >> 199202

Studies of plasma viscosity in primary hyperlipoproteinaemia.

H Leonhardt, H R Arntz, U H Klemens.   

Abstract

Using an Ubbelohde capillary viscometer, viscosity was determined in the plasma of 39 patients with a primary hyperlipoproteinaemia (type IIa, n=13; type IV, n=12; type IIb, n=14), in isolated lipoprotein fractions as well as in sera which differed only in their lipoprotein concentration. Plasma viscosity of the patients with hyperlipoproteinaemia was compared to that of a normolipidaemic control group and correlated with the lipid fractions characteristic of the different hyperlipoproteinaemia types. Plasma viscosity in types IIa, IV and IIb was found to be significantly higher than in the control group. Of the different hyperlipoproteinaemia types, IIa exhibited the lowest and IIb the highest plasma viscosity levels. The elevation of plasma viscosity was correlated with the concentration of lipoproteins (lipid fractions). In viscosity measurements of sera which varied only in lipoprotein concentrations, a correlation between the increase of viscosity and lipoprotein concentration as well as a greater efficiency of VLDL fractions was observed, similar to the viscosity results from isolated lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 199202     DOI: 10.1016/0021-9150(77)90196-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

1.  A prospective study of hyperlipidemia as a pathogenic factor in sudden hearing loss.

Authors:  D Ullrich; G Aurbach; C Drobik
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

2.  Influence of clofibrate on blood viscosity in primary hyperlipoproteinemia.

Authors:  H R Arntz; H Leonhardt; H R Dreykluft
Journal:  Klin Wochenschr       Date:  1979-01-01

Review 3.  Endothelial shear stress and blood viscosity in peripheral arterial disease.

Authors:  Young I Cho; Daniel J Cho; Robert S Rosenson
Journal:  Curr Atheroscler Rep       Date:  2014-04       Impact factor: 5.113

Review 4.  Blood rheology.

Authors:  J Stuart; M W Kenny
Journal:  J Clin Pathol       Date:  1980-05       Impact factor: 3.411

5.  [Predictor function of hemorheologic parameters with reference to the incidence of manifest circulatory disorders: Concept of the Aachen study].

Authors:  H Kiesewetter; F Jung; K H Ladwig; E Waterloh; P Roebruck; R Schneider; G Kotitschke; R Bach
Journal:  Klin Wochenschr       Date:  1986-07-15

6.  Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia.

Authors:  Laszlo Szapary; Beata Horvath; Zsolt Marton; Tamas Alexy; Gabor Kesmarky; Tamas Habon; Monika Szots; Katalin Koltai; Istvan Juricskay; Jozsef Czopf; Kalman Toth
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

7.  Haemorrheological abnormalities in unstable angina pectoris: a relation independent of risk factor profile and angiographic severity.

Authors:  F J Neumann; H Tillmanns; P Roebruck; R Zimmermann; H M Haupt; W Kübler
Journal:  Br Heart J       Date:  1989-12

8.  In vivo shear flow and erythrocyte membrane fluidity in hypertensive patients.

Authors:  K H Le Sang Quan; J Levenson; M Del Pino; A Simon; M A Devynck
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

Review 9.  Hypertriglyceridemia: A Neglected Risk Factor for Ischemic Stroke?

Authors:  Hai-Jie Liang; Qing-Yi Zhang; Yi-Tong Hu; Guo-Qing Liu; Rong Qi
Journal:  J Stroke       Date:  2022-01-31       Impact factor: 6.967

10.  Longxuetongluo Capsule Improves Erythrocyte Function against Lipid Peroxidation and Abnormal Hemorheological Parameters in High Fat Diet-Induced ApoE-/- Mice.

Authors:  Jiao Zheng; Binglin Liu; Qixing Lun; Weijuan Yao; Yunfang Zhao; Wei Xiao; Wenzhe Huang; Yonghua Wang; Jun Li; Pengfei Tu
Journal:  Oxid Med Cell Longev       Date:  2015-11-16       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.